These findings strongly suggest that Parkin could serve as a therapeutic target in cancer treatment, especially in strategies aimed at reactivating silenced tumor suppressor genes to boost intrinsic and extrinsic immune-mediated tumor suppression. Here, PRKN is linked to neoplasm.